Loading cancer entity…
Loading cancer entity…
Clinical trials
404 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01563783 | Post Market TRUST Study(TRUST) | completed | N/A | 84 | Acessa Health, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05643339 | The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler Outcomes(MVF) | completed | — | 30 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 |
| Dec 8, 2022 |
| clinicaltrials |
| NCT02620748 | Use of Intravenous Tranexamic Acid During Myomectomy(TA) | completed | Phase 1 | 60 | George Washington UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT04030182 | Vitamin D Deficit in Women With Uterine Fibroids | completed | — | 127 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 8, 2021 | clinicaltrials |
| NCT04672421 | The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) | completed | N/A | 107 | Shin Poong Pharmaceutical Co. Ltd.INDUSTRY | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04819633 | Evaluating Serum Sestrin in Leiomyoma Patients | completed | — | 61 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT00731341 | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | completed | N/A | 3 | Boston Scientific CorporationINDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT01441635 | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids | completed | Phase 2 | 271 | AbbVie (prior sponsor, Abbott)INDUSTRY | 0 | Jul 13, 2021 | clinicaltrials |
| NCT02925494 | An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 433 | AbbVieINDUSTRY | 3 | Jul 13, 2021 | clinicaltrials |
| NCT03070899 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 1) | completed | Phase 3 | 526 | ObsEva SAINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04736095 | 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas | completed | — | 50 | Aljazeera HospitalOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT03070951 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 2) | completed | Phase 3 | 511 | ObsEva SAINDUSTRY | 9 | Mar 5, 2021 | clinicaltrials |
| NCT03021720 | Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial(SPARQLE) | completed | N/A | 40 | Mount Sinai Hospital, CanadaOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03444987 | The Role of Fibroblast Activation in Uterine Fibroid | completed | — | 35 | Assiut UniversityOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT01840124 | Uterine Leiomyoma Treatment With Radiofrequency Ablation(ULTRA) | completed | N/A | 26 | University of California, San FranciscoOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT01338831 | Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer | completed | Phase 1 | 73 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 17, 2020 | clinicaltrials |
| NCT02260752 | Patient Centered Results for Uterine Fibroids(COMPARE-UF) | completed | — | 3,094 | Duke UniversityOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT03744507 | Bone Mineral Density in Women With Uterine Fibroids or Endometriosis | completed | — | 660 | Myovant Sciences GmbHINDUSTRY | 7 | Nov 10, 2020 | clinicaltrials |
| NCT02189083 | Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids | completed | Phase 3 | 78 | The University of Hong KongOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT04576039 | Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes | completed | N/A | 10 | Universitair Ziekenhuis BrusselOTHER | 1 | Oct 5, 2020 | clinicaltrials |
| NCT03535610 | Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.(EMBOSOFT I) | completed | N/A | 32 | Scitech Produtos Medicos SAINDUSTRY | 1 | Sep 4, 2020 | clinicaltrials |
| NCT03270605 | Myomectomy During CS: A Retrospective Cohort Study | completed | — | 178 | Mansoura UniversityOTHER | 0 | Sep 1, 2020 | clinicaltrials |
| NCT01817530 | Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) | completed | Phase 2 | 571 | AbbVieINDUSTRY | 0 | Jul 21, 2020 | clinicaltrials |
| NCT02812186 | Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery | completed | Phase 4 | 79 | Stony Brook UniversityOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02166411 | Laparoscopic Myomectomy Using Barbed or Conventional Sutures | completed | Phase 2 | 92 | Cairo UniversityOTHER | 1 | Mar 13, 2020 | clinicaltrials |
| NCT02580578 | A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids | completed | — | 1,500 | AllerganINDUSTRY | 1 | Feb 28, 2020 | clinicaltrials |
| NCT03328260 | High Intensity Focused Ultrasound in Uterine Myoma | completed | N/A | 34 | Seoul National University HospitalOTHER | 1 | Jan 3, 2020 | clinicaltrials |
| NCT00044876 | Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist | completed | Phase 2 | 56 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT03411980 | Pharmacokinetics and Safety of Vilaprisan in Renal Impairment | completed | Phase 1 | 26 | BayerINDUSTRY | 1 | Dec 3, 2019 | clinicaltrials |
| NCT02470741 | Pilot of Letrozole for Uterine Myomas(PLUM) | completed | Phase 4 | 12 | University of California, San FranciscoOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01377519 | Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids(PROMISe) | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT02844920 | Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids(OPEN) | completed | — | 37 | GynesonicsINDUSTRY | 4 | Sep 20, 2019 | clinicaltrials |
| NCT03420248 | Comparison of Pain of Two Different Methods in Uterine Artery Embolization | completed | N/A | 54 | Severance HospitalOTHER | 1 | Sep 19, 2019 | clinicaltrials |
| NCT04091529 | Tailored Radiofrequency Ablation of Uterine Myomas | completed | N/A | 54 | International Evangelical HospitalOTHER | 1 | Sep 18, 2019 | clinicaltrials |
| NCT03427671 | OCL 500 Treatment of Women With Symptomatic Uterine Fibroids | completed | N/A | 12 | IMBiotechnologies Ltd.INDUSTRY | 1 | Sep 12, 2019 | clinicaltrials |
| NCT01629563 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIV) | completed | Phase 3 | 451 | PregLem SAINDUSTRY | 11 | Sep 4, 2019 | clinicaltrials |
| NCT02270255 | Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization | completed | Phase 2 | 44 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT00339547 | Risk Factors for Uterine Fibroids: A Case Control Study | completed | — | 1,529 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Jul 25, 2019 | clinicaltrials |
| NCT02889848 | Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) | completed | Phase 1 | 15 | Advance Biofactures CorporationINDUSTRY | 1 | Jul 10, 2019 | clinicaltrials |
| NCT02323646 | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | completed | Phase 2 | 42 | Repros Therapeutics Inc.INDUSTRY | 1 | Jun 25, 2019 | clinicaltrials |
| NCT00839722 | Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas(EFU) | completed | Phase 2 | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 20, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Feb 1, 2023source: clinicaltrials